¼¼°èÀÇ ºñħ½À¼º ½Å°æÀÚ±ØÀåÄ¡ ½ÃÀå º¸°í¼­(2025³â)
Non Invasive Neurostimulation Devices Global Market Report 2025
»óǰÄÚµå : 1769678
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,272,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,065,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,859,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ºñħ½ÀÀû ½Å°æÀÚ±ØÀåÄ¡ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ ±Þ¼ºÀåÀÌ Àü¸ÁµÉ ¿¹Á¤ÀÔ´Ï´Ù. ÀÌ ¼ºÀå Àü¸ÁÀº °í·É Àα¸ Áõ°¡, ¿þ¾î·¯ºí ½Å°æÀÚ±Ø ÀåÄ¡ÀÇ »ç¿ë È®´ë, ÀÇ·áºñ ÁöÃâ Áõ°¡, Á¤ºÎ Áö¿ø Á¤Ã¥ÀÇ ±àÁ¤Àû ¿µÇâ, Á¤½Å °Ç°­ °ü¸® ºÐ¾ß¿¡¼­ÀÇ È°¿ë È®´ë µî°ú ¿¬°üµÇ¾î ÀÖ½À´Ï´Ù. ÁÖ¿ä ½ÅÈï µ¿ÇâÀ¸·Î´Â ÃÖ¼Ò Ä§½À ÀÚ±Ø ±â¼ú·ÎÀÇ Àüȯ, ¹«¼± ½Å°æÀÚ±ØÀåÄ¡ÀÇ Çõ½Å, ¿ø°Ý ÀÇ·á Ç÷§Æû°úÀÇ ÅëÇÕ °­È­, Æó¼âÇü ·çÇÁ ½Ã½ºÅÛÀÇ °³¹ß, °³ÀÎ ¸ÂÃãÇü ½Å°æ ÀÚ±Ø Á¢±Ù¹ýÀÇ Á߿伺 Áõ´ë µîÀÌ ÀÖ½À´Ï´Ù.

½Å°æ°è ÁúȯÀÇ ¹ß»ý·ü Áõ°¡°¡ ÇâÈÄ ºñħ½ÀÀû ½Å°æÀÚ±Ø ÀåÄ¡ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½Å°æ°è ÁúȯÀº ³ú, ô¼ö, ½Å°æ¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÀÇ·áÀû »óÅ·Î, ÀÎÁö, ¿îµ¿, °¨°¢ Àå¾Ö µî ´Ù¾çÇÑ Áõ»óÀ» À¯¹ßÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÁúȯÀÇ ¹ß»ýÀÌ Áõ°¡ÇÏ´Â °ÍÀº Àü ¼¼°è Àα¸ÀÇ °í·ÉÈ­¿Í ¹ÐÁ¢ÇÑ °ü·ÃÀÌ ÀÖ½À´Ï´Ù. °í·ÉÈ­´Â Á¡Â÷ ½Å°æ ±â´ÉÀ» ÀúÇϽÃ۰í, ³úÀÇ °¡¼Ò¼ºÀ» °¨¼Ò½Ã۸ç, »êÈ­ ½ºÆ®·¹½º¸¦ Áõ°¡½ÃÄÑ ½Å°æÇÐÀû ¹®Á¦ÀÇ ¹ßº´ ¹× ÁøÇà¿¡ ±â¿©Çϱ⠶§¹®ÀÔ´Ï´Ù. ºñħ½ÀÀû ½Å°æÀÚ±Ø ÀåÄ¡´Â ½Å°æ ¹ÝÀÀÀ» Æò°¡Çϱâ À§ÇØ Ç¥Àû ÀÚ±ØÀ» Àü´ÞÇÏ¿© ½Å°æ Àå¾ÖÀÇ Áø´Ü¿¡ µµ¿òÀ» ÁÝ´Ï´Ù. ÀÌ ÀåÄ¡´Â ºñ¼ö¼úÀû ½Ç½Ã°£ Æò°¡ ¹æ¹ýÀ» Á¦°øÇÏ¿© Áø´Ü Á¤È®µµ¸¦ ³ôÀ̰í, º´¿ø°ú °¡Á¤¿¡¼­ ȯÀÚ Ä¡·á¸¦ °³¼±ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 7¿ù ¿µ±¹ Á¤ºÎ ±â°üÀÎ ±¹¸³º¸°Ç¼­ºñ½º(NHS)´Â 2024³â 6¿ù 30ÀϱîÁö Ä¡¸Å(±â¾ï·Â, »ç°í·Â, ÀÏ»ó Ȱµ¿¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁøÇ༺ ³ú Áúȯ)·Î Áø´Ü¹ÞÀº ȯÀÚ°¡ 48¸¸ 7,432¸íÀ¸·Î, 2024³â 5¿ù 31ÀÏ ´ëºñ 3,155°Ç Áõ°¡Çß´Ù°í º¸°íÇß½À´Ï´Ù. ÀÌ ½Å°æ°è ÁúȯÀÇ Áõ°¡ Ãß¼¼´Â ºñħ½ÀÀû ½Å°æÀÚ±ØÀåÄ¡ ½ÃÀå ¼ºÀå¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù.

ºñħ½ÀÀû ½Å°æÀÚ±ØÀåÄ¡ ½ÃÀå ÁÖ¿ä ±â¾÷µéÀº Ä¡·á È¿°ú¿Í ȯÀÚ °á°ú¸¦ °³¼±Çϱâ À§ÇØ ¸ÂÃãÇü ÀÚ±Ø ÇÁ·ÎÅäÄݰú °°Àº °í±Þ Á¦Ç° °³¹ß¿¡ ÁýÁßÇϰí ÀÖ½À´Ï´Ù. ¸ÂÃãÇü ÀÚ±Ø ÇÁ·ÎÅäÄÝÀº °³ÀÎÀÇ Æ¯Á¤ ÀÇ·á »óÅÂ, ½Å°æ ¹ÝÀÀ, Ä¡·á ¸ñÇ¥¿¡ ¸Â°Ô ½Å°æ ÀÚ±Ø ¼³Á¤À» Á¶Á¤ÇÏ¿© Ä¡·á È¿°ú¸¦ ±Ø´ëÈ­ÇÏ°í ºÎÀÛ¿ëÀ» ÃÖ¼ÒÈ­ÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 10¿ù Çɶõµå ±â¹Ý ÀÇ·á ±â¼ú ±â¾÷ÀÎ Sooma MedicalÀº ºñħ½ÀÀû °æµÎ°³ Á÷·ù ÀÚ±Ø(tDCS)À» Ȱ¿ëÇÑ °¡Á¤¿ë Ä¡·á¸¦ À§ÇÑ ¿ø°Ý ÀÇ·áÁø ¸ð´ÏÅ͸µ ³ú ÀÚ±Ø ½Ã½ºÅÛÀ» Ãâ½ÃÇß½À´Ï´Ù. ÀÌ Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀº ÀÇ·áÁøÀÌ ¿ø°ÝÀ¸·Î Ä¡·á ¼¼¼ÇÀ» °¨µ¶ÇÒ ¼ö ÀÖµµ·Ï ÇÏ¿© ¿ì¿ïÁõ°ú ¸¸¼º ÅëÁõ°ú °°Àº ½Å°æÇÐÀû ¹× Á¤½Å °Ç°­ ÁúȯÀ» °¡Áø ȯÀÚÀÇ Á¢±Ù¼º°ú Ä¡·á ¼øÀÀµµ¸¦ Çâ»ó½Ãŵ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå : ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ªÀüÀï°ú °ü¼¼, ±×¸®°í Äڷγª 19 ¹× ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°, ±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

HBR
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Non-invasive neurostimulation devices are advanced medical technologies developed to influence neural activity without the need for surgical procedures. These devices utilize external techniques such as electrical, magnetic, or ultrasonic stimulation to focus on particular regions of the nervous system. Their primary objective is to treat neurological and psychiatric disorders like chronic pain, depression, and epilepsy by modifying brain or nerve activity in a safe and efficient manner.

The primary categories of non-invasive neurostimulation devices include transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS), electromagnetic stimulation (EMS), and others. TENS involves the use of low-voltage electrical pulses delivered through the skin using electrodes as a method for non-invasive pain relief. These devices are employed across a variety of clinical applications such as pain management, neurological and psychological disorders, among others. They serve different end users including hospitals and clinics, homecare settings, and academic or research institutions.

The non invasive neurostimulation devices market size has grown rapidly in recent years. It will grow from $1.67 billion in 2024 to $1.89 billion in 2025 at a compound annual growth rate (CAGR) of 13.1%. This growth during the historic period can be credited to a rise in neurological disorder cases, increased awareness about neurostimulation therapies, heightened demand for non-invasive treatment methods, enhanced healthcare infrastructure, and a surge in neuromodulation-related research.

The non-invasive neurostimulation devices market size is expected to see rapid growth in the next few years. It will grow to $3.06 billion in 2029 at a compound annual growth rate (CAGR) of 12.8%. The forecasted growth can be linked to the rising aging population, increased use of wearable neurostimulation devices, growing healthcare spending, favorable government initiatives, and broader use in mental health care. Key emerging trends include a transition to minimally invasive stimulation techniques, innovations in wireless neurostimulation devices, greater integration with telehealth platforms, the development of closed-loop systems, and a growing emphasis on personalized neurostimulation approaches.

The increasing prevalence of neurological disorders is expected to propel the growth of the non-invasive neurostimulation devices market going forward. Neurological disorders are medical conditions that affect the brain, spinal cord, and nerves, leading to a range of symptoms including cognitive, motor, and sensory impairments. The growing occurrence of these conditions is closely linked to the aging global population, as aging gradually impairs neuronal function, reduces brain plasticity, and elevates oxidative stress, contributing to the development and progression of neurological issues. Non-invasive neurostimulation devices assist in diagnosing neurological disorders by delivering targeted stimulation to assess neural responses. They provide non-surgical, real-time evaluation methods, improving diagnostic accuracy and enhancing patient care in both clinical and home settings. For example, in July 2024, the National Health Service, a UK-based government agency, reported 487,432 patients diagnosed with dementia-a progressive brain disorder affecting memory, thinking, and daily activities-by June 30, 2024, marking an increase of 3,155 cases compared to May 31, 2024. This rise in neurological disorders is thereby contributing significantly to the growth of the non-invasive neurostimulation devices market.

Major companies operating in the non-invasive neurostimulation devices market are focusing on developing advanced products such as personalized stimulation protocols to enhance treatment effectiveness and patient outcomes. Personalized stimulation protocols involve tailoring neurostimulation settings to an individual's specific medical condition, neural response, and treatment goals to maximize therapeutic benefits while minimizing side effects. For instance, in October 2023, Sooma Medical, a Finland-based medical technology company, introduced a remote clinician-monitored brain stimulation system designed for at-home treatment using non-invasive transcranial direct current stimulation (tDCS). This innovative solution enables healthcare professionals to supervise therapy sessions remotely, improving accessibility and treatment adherence for patients with neurological and mental health conditions like depression and chronic pain.

In December 2024, ElectroCore Inc., a US-based medical technology company, acquired NeuroMetrix Inc. for an undisclosed amount. This acquisition allowed ElectroCore to expand its portfolio in non-invasive neuromodulation by incorporating NeuroMetrix's Quell pain relief device and DPNCheck diagnostic tool, strengthening its position in the field of bioelectronic medicine. NeuroMetrix Inc. is a US-based neurotechnology company that specializes in non-invasive neurostimulation devices.

Major players in the non invasive neurostimulation devices market are Boston Scientific Corporation, Alpha-Stim, Neurosoft Bioelectronics SA, Neuronetics Inc., BrainsWay Ltd., eNeura Inc., MagVenture A/S, Nexstim Plc, Neuroelectrics Barcelona S.L.U., Cefaly Technology, ElectroCore Inc., Brainbox India Private Limited, Flow Neuroscience AB, Fisher Wallace Laboratories Inc., Sooma Medical, Aleva Neurotherapeutics SA, NeuroSigma Inc., Mind Alive Inc., TheBrainDriver LLC, and Caputron Medical Products LLC.

North America was the largest region in the non invasive neurostimulation devices market in 2024. The regions covered in non-invasive neurostimulation devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the non-invasive neurostimulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The non-invasive neurostimulation devices market consists of revenues earned by entities by providing services such as pain management therapy, cognitive enhancement programs, rehabilitation support, mental health treatment, and remote patient monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The non-invasive neurostimulation devices market also includes sales of transcranial magnetic stimulators (TMS), transcranial direct current stimulators (tDCS), vagus nerve stimulators (non-implantable), external trigeminal nerve stimulators (eTNS), and wearable neurostimulators. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Non Invasive Neurostimulation Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on non invasive neurostimulation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for non invasive neurostimulation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The non invasive neurostimulation devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Non Invasive Neurostimulation Devices Market Characteristics

3. Non Invasive Neurostimulation Devices Market Trends And Strategies

4. Non Invasive Neurostimulation Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Non Invasive Neurostimulation Devices Growth Analysis And Strategic Analysis Framework

6. Non Invasive Neurostimulation Devices Market Segmentation

7. Non Invasive Neurostimulation Devices Market Regional And Country Analysis

8. Asia-Pacific Non Invasive Neurostimulation Devices Market

9. China Non Invasive Neurostimulation Devices Market

10. India Non Invasive Neurostimulation Devices Market

11. Japan Non Invasive Neurostimulation Devices Market

12. Australia Non Invasive Neurostimulation Devices Market

13. Indonesia Non Invasive Neurostimulation Devices Market

14. South Korea Non Invasive Neurostimulation Devices Market

15. Western Europe Non Invasive Neurostimulation Devices Market

16. UK Non Invasive Neurostimulation Devices Market

17. Germany Non Invasive Neurostimulation Devices Market

18. France Non Invasive Neurostimulation Devices Market

19. Italy Non Invasive Neurostimulation Devices Market

20. Spain Non Invasive Neurostimulation Devices Market

21. Eastern Europe Non Invasive Neurostimulation Devices Market

22. Russia Non Invasive Neurostimulation Devices Market

23. North America Non Invasive Neurostimulation Devices Market

24. USA Non Invasive Neurostimulation Devices Market

25. Canada Non Invasive Neurostimulation Devices Market

26. South America Non Invasive Neurostimulation Devices Market

27. Brazil Non Invasive Neurostimulation Devices Market

28. Middle East Non Invasive Neurostimulation Devices Market

29. Africa Non Invasive Neurostimulation Devices Market

30. Non Invasive Neurostimulation Devices Market Competitive Landscape And Company Profiles

31. Non Invasive Neurostimulation Devices Market Other Major And Innovative Companies

32. Global Non Invasive Neurostimulation Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Non Invasive Neurostimulation Devices Market

34. Recent Developments In The Non Invasive Neurostimulation Devices Market

35. Non Invasive Neurostimulation Devices Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â